CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 42,694	$ 81,808
Restricted cash	3,075	1,549
Patient accounts receivable	274,961	255,145
Prepaid expenses	10,356	10,217
Other current assets	25,598	13,265
Total current assets	356,684	361,984
Property and equipment, net of accumulated depreciation of $96,937 and $95,024	18,435	23,719
Operating lease right of use assets	101,257	93,440
Goodwill	1,196,090	932,685
Intangible assets, net of accumulated amortization of $19,900 and $22,973	111,190	74,183
Deferred income taxes	289	47,987
Other assets	73,023	33,200
Total assets	1,856,968	1,567,198
Current liabilities:
Accounts payable	38,217	42,674
Payroll and employee benefits	141,001	146,929
Accrued expenses	150,836	166,192
Provider relief fund advance	0	60,000
Current portion of long-term obligations	12,995	10,496
Current portion of operating lease liabilities	31,233	30,046
Total current liabilities	374,282	456,337
Long-term obligations, less current portion	432,075	204,511
Operating lease liabilities, less current portion	69,309	61,987
Other long-term obligations	4,979	33,622
Total liabilities	880,645	756,457
Commitments and Contingencies
Equity:
Preferred stock, $0.001 par value, 5,000,000 shares authorized; none issued or outstanding	0	0
Common stock, $0.001 par value, 60,000,000 shares authorized; 37,674,868 and 37,470,212 shares issued; and 32,509,969 and 32,814,278 shares outstanding	38	38
Additional paid-in capital	728,118	698,287
Treasury stock at cost, 5,164,899 and 4,655,934 shares of common stock	(435,868)	(319,092)
Retained earnings	639,063	429,991
Total Amedisys, Inc. stockholders’ equity	931,351	809,224
Noncontrolling interests	44,972	1,517
Total equity	976,323	810,741
Total liabilities and equity	$ 1,856,968	$ 1,567,198